Celanese Corp., US1510201049

Celanese Corp. stock holds near USD 46 as Nutrinova sale and valuation debate draw focus

Published on 09/18/2026 at 21:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Celanese Corp. stock closed at USD 46.81 on September 17, 2026 on its primary US exchange, near a fair value estimate of USD 63.63 cited by one analysis. Recent moves include a planned USD 152 million sale of an additional Nutrinova stake to Mitsui.

Luftaufnahme einer großen Spezialchemie-Produktionsanlage bei Sonnenuntergang in Irving Texas
Celanese Corp. Chemieanlagengelände in Irving Texas mit Destillationstürmen und Kühltürmen fotografiert US1510201049, Illustration mit AI erstellt.

Celanese Corp. stock (ISIN US1510201049) closed at USD 46.81 on its primary US exchange on September 17, 2026, leaving the specialty materials group trading well below one widely followed fair value estimate of about USD 63.63 per share.

Nutrinova stake sale sharpens portfolio focus

As Yahoo Finance reported on September 17, 2026, Celanese plans to sell an additional 19 percent stake in its Nutrinova business to Mitsui for USD 152 million, continuing the reshaping of its portfolio around core engineered materials and acetyl chains.

This transaction follows earlier Nutrinova stake sales and gives investors a fresh data point on how Celanese is monetizing non-core assets, with the USD 152 million price tag serving as a reference for valuing the remaining exposure.

Valuation gap and recent performance

According to Simply Wall St on September 18, 2026, Celanese is trading at USD 46.81 versus a fair value estimate of about USD 63.63, implying an undervaluation of roughly 35.9 percent on that model.

The same analysis notes that Celanese shares have gained 11.03 percent year to date and 4.84 percent over the past month, while the three year total shareholder return has fallen 61.52 percent and the five year total shareholder return is down 66.25 percent, illustrating how recent stabilization contrasts with longer term weakness.

Earnings, guidance and dividend context

In its most recent reported quarter, Celanese delivered earnings per share that exceeded consensus expectations, underscoring the importance of operating execution for the investment case. As MarketBeat summarized on September 18, 2026, Celanese most recently posted quarterly earnings per share of USD 2.45, compared with analyst consensus expectations of USD 2.23, beating forecasts by USD 0.22.

For that same quarter, revenue came in at USD 2.75 billion, matching the USD 2.75 billion consensus cited by MarketBeat, highlighting a scenario where earnings beat expectations even as top line performance aligned with forecasts.

Looking ahead, Celanese has set guidance for its third quarter 2026 earnings per share in a range of USD 1.350 to USD 1.750, according to MarketBeat, offering investors a concrete benchmark for upcoming results.

The same overview notes that Celanese recently paid a quarterly dividend of USD 0.03 per share on August 10, 2026 to shareholders of record on July 28, 2026, corresponding to an annualized dividend of USD 0.12 and a yield of about 0.3 percent at recent share price levels, as detailed by MarketBeat.

Institutional positioning and analyst views

Institutional investors continue to adjust their exposure to Celanese, which feeds into liquidity and sentiment around the stock. As MarketBeat reported on September 18, 2026, Corient Private Wealth LP increased its stake in Celanese shares by 59.2 percent during the second quarter.

According to the same MarketBeat report, BlackRock Inc. acquired a new position in Celanese in the second quarter valued at approximately USD 614,675,000, while Capital Research Global Investors boosted its holdings by 24.0 percent in the fourth quarter and Geode Capital Management increased its position by 17.7 percent, illustrating how large asset managers view the stock as part of their broader materials exposure.

On the analyst side, BMO Capital Markets recently adjusted its stance. As MarketBeat noted on September 18, 2026, BMO Capital Markets cut its price target on Celanese shares from USD 57.00 to USD 54.00 and set a market perform rating, framing expectations for moderate performance rather than aggressive outperformance.

Risk factors and sector backdrop

The Nutrinova stake sale to Mitsui underscores Celanese's continuing portfolio transformation, but it also highlights exposure to cyclical end markets in food ingredients and specialty chemicals, where demand patterns can be sensitive to broader economic conditions, as implied by the transaction context described by Yahoo Finance.

At the same time, a broader industry report on high performance materials points to growing opportunities. A recent overview of the carbon fiber tapes market from GlobeNewswire on September 18, 2026 highlights Celanese Corporation among key players benefiting from demand for lightweight, high performance materials in aerospace, automotive and industrial applications, providing a sector level tailwind that can support future growth.

Stock price level and trading context

Celanese Corp. stock closed at USD 46.81 on its primary US exchange on September 17, 2026, with the shares described as trading meaningfully below a fair value estimate of about USD 63.63 from one valuation framework, and against a backdrop of 11.03 percent year to date performance and a 4.84 percent one month return that contrasts with longer term total shareholder return declines of more than 60 percent over three and five year horizons.

Celanese Corp. stock facts

  • Company: Celanese Corp.
  • ISIN: US1510201049
  • Ticker: CE
  • Trading venue: NYSE
  • Price (as of September 17, 2026, 16:00): 46.81 USD
  • Market capitalization: 5.144 billion USD (as of September 16, 2026)
  • Sector / Industry: Materials / Specialty Chemicals
  • Index membership: S&P 500

More news and analyses on Celanese Corp. stock

Disclaimer...

en | US1510201049 | CELANESE CORP. | boerse | 70128218 | bgmi